Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Bories

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Asymptomatic monoclonal gammopathiesClaire Bories, Sundar Jagannath
British Journal of Haematology|May 17, 2018
t(6;9)(p23;q34.1) acute myeloid leukaemia with cup-like blastsClaire Bories, Thomas Boyer
International Journal of Hematology|November 14, 2019
Mature neutrophils with Auer rod bundles in CBFB-MYH11-positive acute myeloid leukemiaNicolas Duployez, Claire Bories
Cancer Medicine|February 12, 2019
CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cellsLucas Touzet, Florent Dumezy, Christophe Roumier, et al.
Expert Review of Hematology|October 1, 2014
Pomalidomide for multiple myelomaGuillemette Fouquet, Claire Bories, Stéphanie Guidez, et al.
European Journal of Haematology|March 4, 2016
Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcriptNicolas Duployez, Olivier Nibourel, Benoît Ducourneau, et al.
Leukemia|December 13, 2019
Familial myeloid malignancies with germline TET2 mutationNicolas Duployez, Laure Goursaud, Laurène Fenwarth, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 1, 2021
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With MyelomaJordane Demonchy, Camille Cordier, Emilie Fréalle, et al.
Leukemia|February 27, 2018
Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutationsChristophe Willekens, Aline Renneville, Sophie Broutin, et al.
British Journal of Haematology|November 20, 2019
Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life populationZoe Van de Wyngaert, Benjamin Carpentier, Laurent Pascal, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Asymptomatic monoclonal gammopathiesClaire Bories, Sundar Jagannath
British Journal of Haematology|May 17, 2018
t(6;9)(p23;q34.1) acute myeloid leukaemia with cup-like blastsClaire Bories, Thomas Boyer
International Journal of Hematology|November 14, 2019
Mature neutrophils with Auer rod bundles in CBFB-MYH11-positive acute myeloid leukemiaNicolas Duployez, Claire Bories
Cancer Medicine|February 12, 2019
CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cellsLucas Touzet, Florent Dumezy, Christophe Roumier, et al.
Expert Review of Hematology|October 1, 2014
Pomalidomide for multiple myelomaGuillemette Fouquet, Claire Bories, Stéphanie Guidez, et al.
European Journal of Haematology|March 4, 2016
Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR-JAK2 fusion transcriptNicolas Duployez, Olivier Nibourel, Benoît Ducourneau, et al.
Leukemia|December 13, 2019
Familial myeloid malignancies with germline TET2 mutationNicolas Duployez, Laure Goursaud, Laurène Fenwarth, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 1, 2021
Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With MyelomaJordane Demonchy, Camille Cordier, Emilie Fréalle, et al.
Leukemia|February 27, 2018
Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutationsChristophe Willekens, Aline Renneville, Sophie Broutin, et al.
British Journal of Haematology|November 20, 2019
Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life populationZoe Van de Wyngaert, Benjamin Carpentier, Laurent Pascal, et al.
Pageof 2